INTRODUCTION
The accurate and timely diagnosis of urinary tract infection (UTI) in children is important to alleviate shortterm suffering 1 and prevent the possible long-term consequences such as renal scarring, impaired renal growth, recurrent pyelonephritis, impaired glomerular function, hypertension, end stage renal disease, and pre-eclampsia. 2 3 4 Guidelines universally recommend urine sampling for microbiological confirmation, by clean catch (preferred in Europe), 5 or catheterization or suprapubic aspiration (SPA) for unwell children where clean catch is not immediately available (preferred in the US 6 and Australia 7 ).
There are three possible explanations why half of UTIs are not diagnosed at the earliest opportunity in UK primary care. 8 First, there is a paucity of primary care relevant evidence regarding which children should be suspected. Guidelines, which emphasise the importance of fever, 6 7 9 are largely informed by studies conducted in emergency departments. 10 11 12 Second, the symptoms and signs of UTI are often non-specific, especially in very young children. Finally, obtaining an uncontaminated sample can be challenging, timeconsuming, and for invasive catheter and SPA sampling methods, painful, 13 frightening 14 and induce infection. 15 We report a large, prospective cohort study designed to investigate the diagnostic features of UTI in young children presenting to primary care. Our aim was to develop and internally validate a two-step clinical rule: step 1 used symptoms and signs to select children for urine sampling and step 2 (once urine was obtained) used symptoms, signs and dipstick testing to guide empiric antibiotic treatment. 'Coefficient' and 'points' based clinical rules were developed for use with and without computer assistance.
METHODS

Design
'DUTY' was a multicenter, prospective, diagnostic cohort study recruiting children presenting to National Health Service (NHS) primary care sites. General Practitioners (GPs), nurses and children's emergency department (CED) doctors (from here on 'clinicians') working in primary care sites (GP clinics, CEDs and Walk-in Centres) are the clinicians who provide primary care for children. Primary care sites were recruited and trained by four UK centre hubs (Bristol, Cardiff, London and Southampton).
Participants
Children were eligible if presenting with any acute (<28 days) illness episode, where the illness was associated with: (a) at least one constitutional symptom or sign identified by the National Institute of Health and Clinical Excellence (NICE) 5 as a potential marker for UTI (fever, vomiting, lethargy/malaise, irritability, poor feeding and failure to thrive); and/or (b) at least one urinary symptom identified by NICE 5 as a potential marker of UTI (abdominal pain, jaundice (children <3 months only), hematuria, offensive urine, cloudy urine, loin pain, frequency, apparent pain on passing urine and changes to continence). As a result, constitutionally unwell children consulting with an apparently obvious cause for their symptoms (such as acute otitis media or bronchiolitis, without a urinary symptom) were included. Children were excluded if: constitutionally well (e.g. acute conjunctivitis only); neurogenic or surgically reconstructed bladder; permanent or intermittent urinary catheter; trauma as the main presenting problem; or antibiotics had been taken within seven days. Clinicians, aided by research nurses where available, were asked to recruit consecutive eligible children and where this was not possible to log children's age and gender (Web 
Index tests and urine collection
Following consent, 107 index tests (symptoms, signs and dipstick results, Web Table 1 ) were recorded on a standardised Case Report Form by qualified clinicians blind to the reference standard. Parent-reported items included the child's medical history and symptoms. Signs, from a full clinical examination, included clinicians' global illness severity impression (zero to ten) and abdominal tenderness. Before urine dipstick testing, clinicians recorded their rating of UTI likelihood ('clinical diagnosis').
Our preferred urine collection method was 'clean catch'. For toilet trained children, we used a sterile bowl that the parent could hold under the child or put in a potty. For other children, the parent cleaned the diaper (nappy) area using water alone and sat the child on their knee with the bowl placed under their perineum. If it was not possible to obtain a sample at the site, the parent was given equipment and advice on taking the sample at home. Where clean catch was not feasible, we used NICE-recommended 'Newcastle Nappy Pads' (a sterile pad placed inside the diaper), 5 but because of differences in contamination rates and children's ages between clean catch and diaper pad samples, the current analysis focuses on clean catch samples.
Urine samples were tested at the site using Siemans/Bayer multistix 8SG dipsticks. Urine samples were split into two fractions for microbiological analysis. The priority fraction was sent to the site's usual laboratory.
When at least 1ml was left, the remainder was sent using first class postal Safeboxes TM in boric acid monovettes to the Public Health Wales Microbiology Specialist Antimicrobial Chemotherapy Unit in Cardiff (the "research laboratory").
Reference standard
The reference standard was determined at the research laboratory, which spiral plated (Don Whitley, United Kingdom (UK)) 50μL of urine onto chromogenic agar and standard blood agar. Quantitative total counts were recorded for up to six organisms and the presence of antimicrobial substances measured.
Samples were processed by two staff members using a single, standardised procedure. As per UK guidelines, 16 our microbiological definition of UTI was either the 'pure' (single) or 'predominant' growth of a uropathogen (an Enterobacteriaceae) at ≥10 5 Colony Forming Units (CFU)/mL. We defined 'predominant' growth as ≥10 5 CFU/mL of a uropathogen with ≥3 log10 (1000-fold) difference between the growth of this and the next species. For comparison, we used the United States (US) definition 6 of a pure uropathogen growth >50,000 CFU/ml with ≥25 white blood cells/mm 3 on microscopy or leucocyte positive (threshold at nil/trace) on dipstick.
Sample size calculation
We assumed a candidate predictor prevalence of 10% and UTI prevalence of 2%. 17 With 80% power and a two-sided alpha of 5%, 3000 urine results were required to detect an odds ratio of 2.4 while 3100 results would give a clinical rule with 80% sensitivity a 95% CI width of 10%. We originally proposed to recruit 4000 children with a target of recovering urines from at least 3,100 (77.5%) for clinical rule derivation and a further 2000 children for external validation. However, we did not anticipate the need to stratify analyses by clean catch/diaper pad collection method. We therefore decided to use all available clean catch results to derive the models, with internal bootstrap validation instead of external validation.
Summary of tatistical analysis
A full description of statistical methods is given in the Web Appendix. In summary, we first compared the age and gender of the children who were recruited with those children whose parents declined to participate. Then, using logistic regression, we estimated associations of index tests with urine culture positivity in two steps (reflecting clinical procedure): in step 1 we used symptoms and signs to select children for urine sampling and in step 2 (once urine was obtained) we used symptoms, signs and dipstick testing to guide empiric antibiotic treatment. 'Coefficient' and 'points' based clinical rules were developed for use with and without computer assistance. We quantified diagnostic accuracy using the area under the receiver operating characteristic (AUROC) curve with 95% confidence interval and internally validated coefficient-based models using the bootstrap procedure described by Steyerberg. 18 Since children presenting with 'fever of unknown origin' is a group of particular clinical interest, we investigated the presence of UTI among children identified as having fever without symptoms or signs suggestive of another source. To assess the added value of dipsticks over symptoms and signs alone we (i) quantified the change in AUROC and (ii) used a simulation procedure to calculate the change in the probability of UTI associated with addition of dipstick results. Finally, since UTI laboratory criteria differ between the UK and US, we calculated the prevalence and bias adjusted kappa statistic to assess agreement between UK and US UTI definitions 19 and used crude and adjusted odds ratios, and the AUROC to assess strength of association, and diagnostic utility, of index tests identified as diagnostic using the UK UTI definition. (Table 1) .
RESULTS
Between
Step 1 -symptoms and signs
The parent-reported index tests associated with UTI in crude (Table 1 ) and adjusted ( Table 2) analyses were pain/crying while passing urine, smelly urine, previous UTI and absence of severe cough. For the first two, there was a graded association with increasing symptom severity. Clinician-reported index tests associated with UTI were increasing illness severity (graded association), abdominal tenderness and absence of ear abnormalities. None of the other index tests (Web Table 1 ) met our criteria for model inclusion, and there was no evidence of association for fever of unknown origin (Web Table 3 ) or prior illness duration (data not shown).
The multiple imputation-based AUROC for the coefficient-based step 1 model was 0.89 (95% CI 0.85 to 0.95, internally validated AUROC 0.88, Table 2 , Figure 1 ). Table 3 (upper) shows diagnostic test characteristics (sensitivity, specificity, positive and negative predictive values, percentage of children defined as positive) according to a range of cutpoints for the symptoms and signs model (for any combination of symptoms and signs, the linear predictor is obtained by adding the coefficients corresponding to those categories to the constant term in Web Table 6 ). To achieve sensitivities of 70% (all children with linear predictor ≥-2.729) or 85% (linear predictor ≥-3.717) with the step 1 model would require urine sampling in 6.8% to 17.6% of children; with corresponding positive predictive values of 22.6% to 10.6% and specificities of 94.6% to 83.9%. While the points-based model had a similar AUROC 0.86 (95% CI 0.81 to 0.90, validated 0.85, Web Table 2 ) to the coefficient-based model, other diagnostic parameters were inferior: using an 85.0% sensitivity (≥3 point cut-off) only increased the post-test probability to 6.9%, with a lower specificity (74.4%) and higher (26.9%) urine collection rate (Web Table 4 , upper). Using a ≥5 point cut-off ("any three of five" symptoms and signs) increased the post-test UTI probability to 17.7%, with increased specificity (94.6%) and reduced urine collection rate (6.4%), but at the expense of reduced sensitivity (51.7%, Web Table 4 (upper) and Figure 2 ).
Urine samples were available for 88, 91 and 612 children <12, 12 to 23, and 24 to 35 months with laboratory confirmed UTI in 4, 2 and 16 of these children respectively (Table 1 ). The coefficient model performed well in children under 3 years, with similar estimated odds and AUROC (Web Table 5 ).
Step 2 -symptoms, signs and dipstick testing
Dipstick leukocytes, nitrites, and blood were strongly associated with UTI (Tables 1 and 2 ). The coefficientbased, multiple imputation model AUROC was 0.93 (95% CI 0.90 to 0.97, validated 0.90), an increase of 0.034 (p=0.009) when dipstick results were added to symptoms and signs (Table 2, Figure 1 ). If all children had a urine sample and dipstick test, the dipstick test results could maintain sensitivity at 80% while improving specificity from 88.3% to 93.8% and reducing the percentage of children treated with antibiotics from 13.2% to 7.8%, assuming immediate antibiotic use ( Table 3 ). The points-based model AUROC was 0.90 (95% CI 0.85 to 0.95, validated 0.89), and increased (by 0.045, p=0.003) when dipstick results were added to symptoms and signs (Table 4 ). Web Table 7 shows there was a substantial impact on the probability of UTI associated with addition of dipstick test results to the step 1 with a median change in post-dipstick test probability of UTI 9.9% (95% range 1.4% to 55.5%).
Serious adverse events
79 (1.1%) of the 7163 recruited children were hospitalized, three related to dipstick testing (two with UTI and one with diabetes).
Effects of replacing US with UK UTI definition
Data were available for all 2740 (100%) children, 35 (1.3%) of whom were UTI positive using the US UTI definition. We found good agreement (prevalence and bias adjusted kappa = 0.98), and crude and adjusted odds ratios were similar, comparing US and UK UTI definitions, showing the same graded associations, except for 'severe cough' (adjusted odds ratio 0.74 (0.23 to 2.37) US compared with 0.29 (0.09 to 0.97) UK, data available from the authors). Step 1 and step 2 diagnostic utilities were stable to the US definition, with validated AUROCs of 0.88 and 0.93 respectively.
DISCUSSION
Summary of findings
In a large cohort of young children presenting with acute illness to primary care, 2.2% of clean catch urine samples met the microbiological criteria for UTI. Based on data obtained from clean catch samples, we developed novel coefficient (for computer use) and points-based clinical rules to help clinicians identify children for urine sampling and antibiotic treatment with high diagnostic utility. For step 1, the coefficientbased rule was diagnostically superior to the points-based rule, which in turn, was superior to clinical diagnosis. For step 2, dipstick testing was diagnostically superior to symptoms and signs alone (both coefficient and points-based rules), and was not diagnostically useful in children with the lowest UTI probability, in whom step 1 would not result in urine collection.
Strengths and limitations
To our knowledge, this is the largest and most rigorous diagnostic accuracy study of UTI in children under five years in primary care. The generalisability of the final sample is supported by the similarity between participating children and those invited but declining. We achieved high levels of data completeness across a large number of primary care sites and maintained blinding of recruiting staff to the reference standard.
Index tests were measured according to routine clinical practice using standardised reporting forms and equipment, and nearly all were completed within 24 hours of urine sample retrieval, minimising disease progression bias. The low number of samples with antimicrobial substances minimises treatment paradox.
Our reference standard was specific to common uropathogens, and excluded index tests. Two members of staff, blind to all index tests bar age, performed the microbiological cultures and interpreted results, using a standardised process in a single laboratory. Our broad eligibility criteria allowed us to identify previously unidentified clinical features useful for both increasing (smelly urine) and decreasing (absence of severe cough, normal ear examination) UTI probability, as well as demonstrate the absence of diagnostic utility of other features (such as fever, fever of unknown origin, vomiting, lethargy, irritability and poor feeding) widely believed 5 6 to be diagnostically useful. Our results are stable using the more conservative US definition of UTI.
The main limitation is the relatively small number of UTI diagnoses, especially in the youngest children, which impacted on three areas. First, we were not able to externally validate our rules. While external validation is desirable prior to clinical application, bootstrap validation takes account of model overoptimism. By analogy, it is reasonable for clinical practice to change on the basis of a single, high-quality, well conducted randomised trial, though replication is desirable. That said, since we recruited from 'firstpoint-of-contact' primary care sites, we consider it necessary to evaluate the rule's performance prior to use in secondary care. Second, our rule development breached the widely quoted "10 events per candidate predictor". However, this rule of thumb has little theoretical justification, has been shown to be conservative, 22 and the consequences of variable selection are strongly dependent on the strength of association of candidate predictors with the outcome. Here, predictors of UTI are biologically plausible and associations substantial. Finally, children under two years are under-represented in these analyses because of the difficulty of obtaining clean catch samples in this age group. However, we found our rule to be diagnostically accurate in children under three years able to provide a clean catch urine sample. Our secondary care experience, and a recent report describing a bladder stimulation technique for infants, 23 suggest that when sufficient time, space and personnel are available, clean catch sampling is possible in most young children.
We mitigated the impact of false positive urine cultures (arising as a result of asymptomatic bacteriuria 24 or contamination) using three design features. First, children were only eligible if experiencing constitutional and/or urinary symptoms; second, the rule was developed only using clean catch samples; and third, we used a single research laboratory, which used methods superior to NHS laboratories to distinguish contaminated urine. Incorporation bias could have inflated the AUROC for step two using the US definition of UTI since dipstick leucocytes were used as both an index test and within reference standard definition.
Results in context with other studies
One systematic review of eight primary studies (7892 children), 25 and five primary studies 10 11 26 27 28 of a further 18,796 children (with only one 26 conducted in GP surgeries) have assessed UTI prevalence and the diagnostic value of clinical symptoms and signs in children <5 years. 29 These found similar UTI prevalence and showed abdominal pain, back pain, dysuria, frequency, and new-onset urinary incontinence were positively associated with UTI. 25 Stridor, audible wheeze, circumcision, temperature <39°C with a source, abnormal chest sounds, chest crackles, age under three years, not feeling hot, and rapid breathing were inversely associated with UTI. The largest study, which included 16,000 children presenting to the CED, derived a complex model based on 27 symptoms and signs, with an AUROC of 0.80 (95% CI 0.78 to 0.82). 27 The only previous study to recruit from GP surgeries found that younger age, urinary frequency and pain/crying on passing urine were associated with UTI, but had insufficient children with UTI to develop a clinical rule. 26 Previous investigation of malodorous urine has shown conflicting results, 28 30 but our study strongly supports its diagnostic value. Dipstick testing has been considered diagnostically unhelpful in young children. 5
Clinical and research implications
In keeping with recently updated US guidelines, 6 our results support a 'risk-based' approach to the identification of children for investigation of UTI. Pain or crying while passing urine, smelly urine, previous UTI, absence of severe cough, severe illness, abdominal tenderness, and absence of ear abnormalities can be used for deciding which children to urine sample (step 1) and dipstick results to improve specificity for antibiotic treatment (step 2). For both steps, increasing diagnostic sensitivity can be achieved by increasing urine sampling rates, which may not be feasible or affordable. Precisely how these results are used is likely to depend on clinician preference. Some clinicians may wish to use these as "risk factors" to feed into clinical judgement. Others may prefer to use a "check list" approach and use the points-based clinical rules ( Figure 2 , which can be used without computer assistance) which focus attention on predictive factors rather than those (such as fever) with poor diagnostic utility. Clinicians concerned about over-diagnosis and treatment could select a higher specificity threshold, while higher sensitivity thresholds would reduce under-diagnosis. When the rule is used, it should supplement not replace clinical judgement.
Further research is needed to distinguish pathogens from contamination and asymptomatic bacteriuria. 24 Given the expense of an external validation study, and the low rates of routine urine sampling (which render routine datasets unsuitable), we consider the most cost-effective future research strategy would be to assess the impact of the DUTY clinical rule on clinical behaviour and patient outcome in a randomised trial, and that the strongest design would integrate the presentation of the coefficient-based clinical rule within routine clinical care, probably via electronic medical records.
CONCLUSIONS
Our rule can be used to enhance current clinical practice in the identification of young children for noninvasive urine sampling in primary care. Fever should not be used to stratify UTI probability and dipstick testing can be used to improve specificity for empiric antibiotic treatment in this population. 
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